Archive for category: Life Sciences

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+™ allergy immunotherapy product candidates

/ October 19, 2017 9:00 am

Brussels, Belgium, October 17, 2017, 6:30 pm (CEST) – ASIT biotech (Euronext: ASIT – BE0974289218), a Belgian clinical-stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough immunotherapy products for the treatment of allergies, announces the positive […]

BioArctic’s Patent for its Product Candidate Antibody BAN0805, for Parkinson’s Disease, is Now Granted in Europe

BioArctic’s Patent for its Product Candidate Antibody BAN0805, for Parkinson’s Disease, is Now Granted in Europe

/ October 13, 2017 8:53 am

Stockholm, Sweden, October 13, 2017 – BioArctic AB (publ) (Nasdaq Stockholm:BIOA B) today announced that the European Patent Office (EPO) has decided to grant a European patent (EP2539366) to BioArctic AB and the patent will be published on November 08, 2017. […]

CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE’S MECHANISM OF ACTION IN MAKING TUMORS ‘VISIBLE’ TO THE IMMUNE SYSTEM

CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE’S MECHANISM OF ACTION IN MAKING TUMORS ‘VISIBLE’ TO THE IMMUNE SYSTEM

/ October 13, 2017 8:45 am

CEL-SCI Corporation (NYSE American: CVM) announced today that the European Patent Office has issued a new patent to CEL-SCI for its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), which is currently in a pivotal Phase 3 trial for head and neck cancer. […]

New Patents Granted to Sabinsa’s Cosmetics Division in US And EU

New Patents Granted to Sabinsa’s Cosmetics Division in US And EU

/ September 26, 2017 12:49 pm

Sabinsa Cosmetics, a division of the Sami Labs – Sabinsa Group, has been granted two new patents on novel cosmetic compositions, both developed from extensive research on combinations of the companies branded ingredients. These most recent patents are likely to […]

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

Cantargia obtains patent approval in Europe for the antibody CAN04 in development for treatment of cancer

/ September 14, 2017 10:00 am

Cantargia AB (”Cantargia”) today announced that the European Patent Office (“EPO”) has granted the company’s patent application on the product candidate CAN04. CAN04 is targeted against the molecule IL1RAP expressed in a large number of cancer diseases. The formal approval […]

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

RegeneRx Collaborators Receive Notice of ‘Intent to Grant’ EU Patent for the Treatment of Peripheral Neuropathy

/ August 22, 2017 8:32 am

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent Office (EPO) has issued an Intent to Grant notice related to Thymosin beta 4 […]

Suven Life secures Process Patents in Europe, Japan and New Zealand

Suven Life secures Process Patents in Europe, Japan and New Zealand

/ August 17, 2017 8:16 am

Suven Life Sciences Ltd (Suven) announces today that the grant of of one (1) process patent from Europe (3077375), one (1) process patent from Japan (6151453) and one (1) process patent from New Zealand (719671) corresponding to the New Chemical Entities (NCEs) which […]

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

European Patent Office to Grant Merck’s Patent Application for CRISPR Technology

/ August 10, 2017 9:50 am

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favourable outcomes anticipated Darmstadt, Germany, August 3, 2017 — Merck, a leading […]

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

/ August 4, 2017 8:00 am

AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), announced that it has received grant status for the patent application: PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN-B IN PLANTS (EP3013963) from the European Patent Office. Exogenous pulmonary surfactant is routinely being used in surfactant […]

EnteroMedics Announces Receipt of European Patent Certificate

EnteroMedics Announces Receipt of European Patent Certificate

/ July 26, 2017 9:31 am

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the receipt of a European Patent Certificate.  The Company was granted Patent number 2254659 titled “Treatment of excess weight by […]